Asterias Biotherapeutics Inc (AST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Sales | 1,594 | 608 | 1,423 | 772 | 779 |
| Cost of Goods | 53 | 3 | 176 | 38 | 51 |
| Gross Profit | 1,541 | 605 | 1,247 | 734 | 728 |
| Operating Expenses | 12,686 | 8,236 | 6,359 | 5,579 | 5,316 |
| Operating Income | -11,092 | -7,628 | -4,936 | -4,807 | -4,537 |
| Interest Expense | 147 | 144 | 126 | 51 | 20 |
| Other Income | 0 | 1 | -6 | -1 | 0 |
| Pre-tax Income | -11,239 | -7,771 | -5,068 | -4,859 | -4,557 |
| Income Tax | -902 | -2,866 | -1,561 | -1,241 | -1,584 |
| Net Income Continuous | -10,337 | -4,905 | -3,507 | -3,618 | -2,973 |
| Net Income | $-10,337 | $-4,905 | $-3,507 | $-3,618 | $-2,973 |
| EPS Basic Total Ops | -0.27 | -0.14 | -0.09 | -0.10 | -0.09 |
| EPS Basic Continuous Ops | -0.27 | -0.13 | -0.09 | -0.10 | -0.09 |
| EPS Diluted Total Ops | -0.27 | -0.14 | -0.09 | -0.10 | -0.09 |
| EPS Diluted Continuous Ops | -0.27 | -0.13 | -0.09 | -0.10 | -0.09 |
| EBITDA(a) | $-10,118 | $-6,767 | $-4,111 | $-3,983 | $-3,712 |